Energenesis Biomedical CO.,LTD.

TWSE:6657 Stock Report

Market Cap: NT$4.1b

Energenesis BiomedicalLTD Balance Sheet Health

Financial Health criteria checks 6/6

Energenesis BiomedicalLTD has a total shareholder equity of NT$643.5M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$673.2M and NT$29.7M respectively.

Key information

0%

Debt to equity ratio

NT$0

Debt

Interest coverage ration/a
CashNT$556.21m
EquityNT$643.49m
Total liabilitiesNT$29.74m
Total assetsNT$673.22m

Recent financial health updates

Recent updates

We Think Energenesis BiomedicalLTD (GTSM:6657) Can Easily Afford To Drive Business Growth

Apr 20
We Think Energenesis BiomedicalLTD (GTSM:6657) Can Easily Afford To Drive Business Growth

We're Hopeful That Energenesis BiomedicalLTD (GTSM:6657) Will Use Its Cash Wisely

Dec 15
We're Hopeful That Energenesis BiomedicalLTD (GTSM:6657) Will Use Its Cash Wisely

Financial Position Analysis

Short Term Liabilities: 6657's short term assets (NT$578.3M) exceed its short term liabilities (NT$27.4M).

Long Term Liabilities: 6657's short term assets (NT$578.3M) exceed its long term liabilities (NT$2.3M).


Debt to Equity History and Analysis

Debt Level: 6657 is debt free.

Reducing Debt: 6657 had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 6657 has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: 6657 has sufficient cash runway for 2.1 years if free cash flow continues to reduce at historical rates of 19.9% each year.


Discover healthy companies